一表列出瑞信對上海「封城」對各行業影響預測及相關推介股份
瑞信發表報告,列出對上海因疫情「封城」對各行業影響預測:
(一)製造業
行業│影響
(1)汽車│上海佔中國汽車銷售3.5%,料30%零部份件輸出由於長時間的封鎖,使零部件供應面臨風險,4月行業生產或受到巨大影響
(2)科技│硬件、軟件會受影響,但芯心影響屬可控
(3)工業│產量中斷有限,但需求面臨逆風
(二)線上消費
(1)電商│付運延遲,線上零售需求減
(2)外賣│供應呈樽頸,餐飲服務騎手短缺
(3)按需求的生活百貨│需求測試其採購和履行能力
(4)線上旅遊│上海航空線路取消,需求轉至本地
(三)其他消費
(1)餐飲│料損失1個月收入
(2)體育用品│料損失1個月收入,高端產品影響較大
(3)啤酒│上海佔全行業銷量屬低位單位數字,高端產品影響較大
(4)乳製品│上海佔全行業收入單位數字
(5)美容│4月至5月行業高峯期受壓
此外,該行亦列出此情境下的推介股份:
股份│投資評級│目標價
石藥集團(01093.HK)│跑贏大市│13元
君實生物(01877.HK)│跑贏大市│65元
復星醫藥(02196.HK)│跑贏大市│42元
美團(03690.HK)│跑贏大市│245元
叮咚買菜(DDL.US)│跑贏大市│17美元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.